Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00031161 · ClinicalTrials.gov registry record · NA

Prevention of Dichloroacetate Toxicity

A NA study of Chronic Disease and Acidosis, Lactic, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT00031161 is a NA study of Chronic Disease and Acidosis, Lactic that has completed, run by University of Florida. The registered enrollment target is 30 participants, below the 89,943-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00031161, a NA study of Chronic Disease and Acidosis, Lactic, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This is a study to determine the safety of dichloroacetate (DCA) with a low-tyrosine diet given with or without nitisinone (NTBC) in children with chronic lactic acidosis (CLA).

Interventions

  • DRUG Dichloroacetate
  • DRUG Nitisinone (NTBC)
  • BEHAVIORAL Low-tyrosin diet

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2001-09
Est. Completion 2005-09
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT00031161

The ClinicalTrials.gov registry entry for NCT00031161 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 89,943-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Disease appearing as the primary indexed condition, and to 3 interventions - of which Dichloroacetate is the first listed.

NCT00031161 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT00031161 about?

NCT00031161 is a clinical study titled "Prevention of Dichloroacetate Toxicity". This is a study to determine the safety of dichloroacetate (DCA) with a low-tyrosine diet given with or without nitisinone (NTBC) in children with chronic lactic acidosis (CLA).

What is the current status of trial NCT00031161?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2001-09. Estimated completion is 2005-09.

What conditions does trial NCT00031161 study?

This clinical trial studies the following conditions: Chronic Disease, Acidosis, Lactic.

What interventions are being tested in trial NCT00031161?

The interventions under investigation include: Dichloroacetate (DRUG), Nitisinone (NTBC) (DRUG), Low-tyrosin diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT00031161?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00031161 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.